Given that ATPIF1-mediated metabolic pathways such as glycolysis and OXPHOS had been reported to be widely involved in chemotherapeutic resistance (4), we examined the possible response to three chemotherapeutic agents in GC cells with miR-148b-5 overexpression. Here, ATP5IF1 is linked to gastric cancer.